Malchesky P S, Skibinski C I, Williams G W, Nosé Y
Artif Organs. 1987 Apr;11(2):173-82. doi: 10.1111/j.1525-1594.1987.tb02653.x.
Results of the second pilot of the International Apheresis Registry for 1983 involving 37 centers on four continents are presented. This report is a follow-up of the initial pilot reported previously and includes the results of 37 additional centers reporting on 659 patients for a total of 5,780 treatments. The results were collected through a single-page questionnaire. Information gathered included patient demographics, medical history, treatment specifics (type, methodology, access type, anticoagulants, drugs), side effects, response, and payment provider. The data are grouped by regions (East, Europe, and North America). Analysis of the data identifies the regional differences in apheresis usage and treatment specifics, suggesting that an international view of apheresis is more representative of this therapeutic modality than national results, which are highly dependent on the local economics and available technology.
本文呈现了1983年国际单采血液成分登记处第二次试点的结果，该试点涉及四大洲的37个中心。本报告是之前首次试点的后续报告，纳入了另外37个中心报告的659例患者的结果，共计5780次治疗。结果通过单页问卷收集。收集的信息包括患者人口统计学资料、病史、治疗细节（类型、方法、通路类型、抗凝剂、药物）、副作用、反应和支付提供者。数据按地区（东亚、欧洲和北美）分组。对数据的分析确定了单采血液成分使用和治疗细节的地区差异，这表明单采血液成分的国际视角比高度依赖当地经济和现有技术的国家结果更能代表这种治疗方式。
